Drug prescription in pregnancy: analysis of a large statutory sickness fund population

被引:79
作者
Egen-Lappe, V [1 ]
Hasford, J [1 ]
机构
[1] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, D-81377 Munich, Germany
关键词
D O I
10.1007/s00228-004-0817-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To examine the prescription of drugs in Germany prior to, during and after pregnancy. Methods: For the first time, prescription data of a large cohort of pregnant women, from a German statutory sickness fund, were available for scientific analysis. For each woman who gave birth between June 2000 and May 2001 reimbursed prescriptions for two periods (90 days each) before pregnancy, three during and two after delivery were considered. The drugs were classified according to the ATC code. Results: Of the 41.293 women, 96.4% received at least one drug during pregnancy. A median of 7 drugs per women was prescribed. Excluding vitamins, minerals, iodide and iron, 85.2% received at least one drug and the median was 3. Magnesium, which was seldom prescribed outside of pregnancy, was by far the most frequently prescribed substance (20% of all prescriptions, 61% of the women). Iron (54% of the women) and iodide (31%) were also prescribed often. The prescription rates of gynaecological antiinfectives (maximum in third trimester: 23% of the women), antacids (max. in third trim.: 11%). as well as antiemetics and antinauseants (max. in first trim.: 8%) during pregnancy considerably increased. A decrease was seen for analgesics, antiinflammatory and antirheumatic drugs, muscle relaxants, ophtalmologicals and anti-acne preparations, for example. Potential teratogenic drugs were prescribed to 1.3% of the women. Conclusion: This analysis of a large nation-wide cohort of pregnant women showed that during pregnancy drugs were prescribed to most women, even when vitamins, minerals, iodide and iron were omitted. Magnesium and iron seemed to have been over-prescribed. On the other hand, the official recommendation for iodide substitution, to prevent thyroid diseases in mother and child, was insufficiently implemented. In our opinion, regular analysis of prescription data can identify potential harmful therapies and focal points where guidelines are needed and can check their implementation.
引用
收藏
页码:659 / 666
页数:8
相关论文
共 23 条
  • [1] Prescription of drugs to pregnant women in France: the HIMAGE study
    Beyens, MN
    Guy, C
    Ratrema, M
    Ollagnier, M
    [J]. THERAPIE, 2003, 58 (06): : 505 - 511
  • [2] DRUG-USE IN PREGNANCY - AN OVERVIEW OF EPIDEMIOLOGIC (DRUG UTILIZATION) STUDIES
    BONATI, M
    BORTOLUS, R
    MARCHETTI, F
    ROMERO, M
    TOGNONI, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (04) : 325 - 328
  • [3] BONATI M, 1992, INT J GYNECOL OBSTET, V39, P185
  • [4] Therapeutic drug use during pregnancy:: A comparison in four European countries
    De Vigan, C
    De Walle, HEK
    Cordier, S
    Goujard, J
    Knill-Jones, R
    Aymé, S
    Calzolari, E
    Bianchi, F
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (10) : 977 - 982
  • [5] DRUG-USE IN PREGNANCY - A COMPARATIVE APPRAISAL OF DATA COLLECTING METHODS
    DEJONGVANDENBERG, LTW
    WAARDENBURG, CM
    HAAIJER-RUSKAMP, FM
    DUKES, MNG
    WESSELING, H
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (01) : 9 - 14
  • [6] INVESTIGATING DRUG-USE IN PREGNANCY - METHODOLOGICAL PROBLEMS AND PERSPECTIVES
    DEJONGVANDENBERG, LTW
    VANDENBERG, PB
    HAAIJER-RUSKAMP, FM
    DUKES, MNG
    WESSELING, H
    [J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1991, 13 (01) : 32 - 38
  • [7] *DTSCH GES GYN GEB, 1993, FRAUENARZT, V34, P10
  • [8] EGEN V, 2002, PHARMACOEPIDEM DR S, V11, pS148
  • [9] GROSPIETSCH G, 2000, ERKRANKUNGEN SCHWANG, P298
  • [10] HOFFMANN A, 1992, INT J CLIN PHARM TH, V30, P462